POST KALA-AZAR DERMAL LEISHMANIASIS
Clinical trials for POST KALA-AZAR DERMAL LEISHMANIASIS explained in plain language.
Never miss a new study
Get alerted when new POST KALA-AZAR DERMAL LEISHMANIASIS trials appear
Sign up with your email to follow new studies for POST KALA-AZAR DERMAL LEISHMANIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Old drug, new hope? ivermectin tackles stubborn skin disease
Disease control CompletedThis early study tested whether the drug ivermectin could safely treat post-kala-azar dermal leishmaniasis (PKDL), a skin condition that can appear after recovery from visceral leishmaniasis. Ten otherwise healthy adults with PKDL took ivermectin pills for five days each month fo…
Matched conditions: POST KALA-AZAR DERMAL LEISHMANIASIS
Phase: EARLY_PHASE1 • Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Old drug, new hope? ivermectin tested for stubborn skin disease
Disease control CompletedThis early study tested whether the common anti-parasite drug ivermectin could treat post-kala-azar dermal leishmaniasis (PKDL), a skin condition that can spread a serious disease. Thirty people in Bangladesh received either ivermectin pills for 3 months or the standard drug milt…
Matched conditions: POST KALA-AZAR DERMAL LEISHMANIASIS
Phase: EARLY_PHASE1 • Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Disease control
Last updated Jun 26, 2026 16:42 UTC